Childhood Non-Hodgkin Lymphoma Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Get More Information From NCI
Call 1-800-4-CANCERFor more information, U.S. residents may call the National Cancer Institute's (NCI's) Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) Monday through Friday from 8:00 a.m. to 8:00 p.m., Eastern Time. A trained Cancer Information Specialist is available to answer your questions.Chat online The NCI's LiveHelp® online chat service provides Internet users with the ability to chat online with an Information Specialist. The service is available from 8:00 a.m. to 11:00 p.m. Eastern time, Monday through Friday. Information Specialists can help Internet users find information on NCI Web sites and answer questions about cancer. Write to usFor more information from the NCI, please write to this address:NCI Public Inquiries Office9609 Medical Center Dr. Room 2E532 MSC 9760Bethesda, MD 20892-9760Search the NCI Web siteThe NCI Web site provides online access to information on cancer, clinical trials, and other Web sites and organizations that offer support
Adult Non-Hodgkin Lymphoma Treatment (PDQ®): Treatment - Health Professional Information [NCI] - General Information About Adult Non-Hodgkin Lymphoma (NHL)
The NHLs are a heterogeneous group of lymphoproliferative malignancies with differing patterns of behavior and responses to treatment.Like Hodgkin lymphoma, NHL usually originates in lymphoid tissues and can spread to other organs. NHL, however, is much less predictable than Hodgkin lymphoma and has a far greater predilection to disseminate to extranodal sites. The prognosis depends on the histologic type, stage, and treatment.Incidence and MortalityEstimated new cases and deaths from NHL in the United States in 2013:New cases: 69,740.Deaths: 19,020.AnatomyNHL usually originates in lymphoid tissues.Anatomy of the lymph system.Prognosis and SurvivalThe NHLs can be divided into two prognostic groups: the indolent lymphomas and the aggressive lymphomas. Indolent NHL types have a relatively good prognosis with a median survival as long as 10 to 20 years, but they usually are not curable in advanced clinical stages. Early-stage (stage I and stage II) indolent NHL can be effectively
WebMD explains Burkitt lymphoma, including its symptoms, causes, and treatments.
Acute Myeloid Leukemia
WebMD explains acute myeloid leukemia (AML), a type of blood cancer, including symptoms, risk factors, and treatments.
Acute Lymphoblastic Leukemia
WebMD explains acute lymphoblastic leukemia (ALL), including its symptoms, risk factors, and treatments.
WebMD explains multiple myeloma, a blood disorder, including its risk factors, symptoms, diagnosis, and treatments.
Understanding Leukemia -- Diagnosis and Treatment
A look at the treatment of leukemia from the experts at WebMD.
Understanding Leukemia -- the Basics
Get the basics about leukemia from the experts at WebMD.
Understanding Leukemia -- Symptoms
Information on the symptoms of leukemia.
Understanding Non-Hodgkin Lymphoma -- Diagnosis & Treatment
Learn more about the diagnosis and treatment of non-Hodgkin lymphoma from the experts at WebMD.